Medtronic PLC (MDT.N) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Wright Reports
$75.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medtronic Inc receives FDA approval for PRESTIGE LP cervical disc system


Monday, 28 Jul 2014 12:44pm EDT 

Medtronic Inc:Receives approval from the U.S. Food and Drug Administration (FDA) to market PRESTIGE LP Cervical Disc System for treatment of single-level cervical disc disease (radiculopathy and/or myelopathy).